Key Takeaways
- myTomorrows partners with Scout to enhance cross-border recruitment for clinical trials, alleviating logistical and financial challenges.
- The collaboration leverages AI and logistics solutions to improve patient access to treatment options and streamline trial enrollment.
- The initiative aims to ensure a diverse patient pool and faster recruitment, ultimately benefiting global clinical research.
Enhancing Clinical Trial Access
myTomorrows, a health technology company focused on connecting patients with treatment options, has formed a partnership with Scout, a provider of services and technology in the biopharmaceutical sector. This collaboration seeks to tackle the emotional, logistical, and financial challenges that patients face with international clinical trial recruitment.
Global clinical research often encounters barriers such as fragmented information systems, varying regulations, and complex logistical arrangements, including visa processes. These hurdles can extend recruitment timelines and restrict patient diversity, particularly for trials involving rare diseases or stringent eligibility criteria.
The partnership between myTomorrows and Scout aims to improve the patient experience by integrating trial matching with personalized support services for both domestic and international needs. myTomorrows’ Patient Navigator team assists patients with identifying suitable trials and conducting pre-screening, while Scout offers logistical support, including travel arrangements, expense reimbursements, and accommodation. These measures are designed to ease the burdens placed on patients, their families, and caregivers.
Scout’s CEO, Moisha Platto, highlighted the advantages this partnership presents to all stakeholders involved in the clinical trial ecosystem. By addressing barriers early in the process, trial sites can more efficiently manage international patient intake, offering clarity to patients about their treatment options and enhancing enrollment experiences.
The collaboration aims to revolutionize recruitment outcomes through advanced logistics and artificial intelligence. By expanding global reach and diversifying enrollment pools, Scout can help researchers meet their recruitment goals more effectively. Moreover, myTomorrows is enhancing the efficiency of eligibility criteria checks—reducing the time required for physicians by 90% compared to traditional methods.
Dr. Michel van Harten, CEO of myTomorrows, emphasized the collective goal of removing geographical barriers so that every patient can access participation in clinical trials. By connecting trial sites beyond immediate geographical confines, the partnership is set to facilitate better patient journeys and accelerate clinical research.
This collaboration marks an important advancement in global clinical research, providing patients worldwide with improved access to potentially transformative treatments. Together, myTomorrows and Scout are working to make clinical trial participation more accessible and manageable, enhancing the prospect of successful patient outcomes.
The content above is a summary. For more details, see the source article.